Investors & News

Home  >  Investors & News  >  News Releases  >  Press Release Details

Press Release Details

View all news

Clovis Oncology to Present at the 37th Annual J.P. Morgan Healthcare Conference

January 02, 2019

BOULDER, Colo.--(BUSINESS WIRE)-- Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that its Chief Executive Officer and President, Patrick J. Mahaffy, will present at the 37th Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2019 at 4:30 p.m. Pacific time. The conference will be held at the Westin St. Francis Hotel in San Francisco.

A live webcast of the presentation and Q&A session can be accessed through the investor relations section of the Company’s website at www.clovisoncology.com. Following the live presentation, a replay of the webcast will be available on the Company’s website for 30 days.

About Clovis Oncology

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops, with partners, diagnostic tools intended to direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado, and has additional offices in San Francisco and Oakland, California and Cambridge, UK. Please visit clovisoncology.com for more information.

Clovis Oncology
Anna Sussman
303.625.5022
asussman@clovisoncology.com
or
Breanna Burkart
303.625.5023
bburkart@clovisoncology.com

Source: Clovis Oncology

Categories: Press Releases
View all news